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An incoherent feedforward loop interprets NFκB/
RelA dynamics to determine TNF-induced
necroptosis decisions
Marie Oliver Metzig1,2, Ying Tang1,2, Simon Mitchell1,2,†, Brooks Taylor1,2, Robert Foreman2,3,4 ,
Roy Wollman2,3,4 & Alexander Hoffmann1,2,*
Abstract
Balancing cell death is essential to maintain healthy tissue home-
ostasis and prevent disease. Tumor necrosis factor (TNF) not only
activates nuclear factor κB (NFκB), which coordinates the cellular
response to inflammation, but may also trigger necroptosis, a pro-
inflammatory form of cell death. Whether TNF-induced NFκB
affects the fate decision to undergo TNF-induced necroptosis is
unclear. Live-cell microscopy and model-aided analysis of death
kinetics identified a molecular circuit that interprets TNF-induced
NFκB/RelA dynamics to control necroptosis decisions. Inducible
expression of TNFAIP3/A20 forms an incoherent feedforward loop
to interfere with the RIPK3-containing necrosome complex and
protect a fraction of cells from transient, but not long-term TNF
exposure. Furthermore, dysregulated NFκB dynamics often associ-
ated with disease diminish TNF-induced necroptosis. Our results
suggest that TNF’s dual roles in either coordinating cellular
responses to inflammation, or further amplifying inflammation are
determined by a dynamic NFκB-A20-RIPK3 circuit, that could be
targeted to treat inflammation and cancer.
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Introduction
The cytokine tumor necrosis factor (TNF) mediates diverse cell fate
decisions in response to inflammation (Fig EV1A) (Beutler et al,
1985a; Newton & Dixit, 2012). TNF-induced activation of nuclear
factor κB (NFκB) regulates the expression of hundreds of
inflammatory response genes involved in eliminating pathogens,
resolving inflammation and healing (Wallach et al, 1999; Cheng
et al, 2017). However, TNF is also a cell-killing agent (Carswell
et al, 1975; Beutler et al, 1985a) and may trigger apoptotic or
necroptotic cell death programs with distinct pathophysiological
consequences (Vandenabeele et al, 2010). While apoptotic cells
fragment into membrane bound vesicles, which allows their
removal and resolution of inflammation (Galluzzi et al, 2018),
necroptotic cells spill damage-associated molecular patterns
(DAMPs) into the microenvironment, which promotes inflammation
(Pasparakis & Vandenabeele, 2015; Wallach et al, 2016). Indeed,
necroptosis has been linked to acute and chronic inflammatory
diseases (Ito et al, 2016; Newton et al, 2016; Shan et al, 2018), and
inhibition may be a promising therapeutic strategy (Degterev et al,
2019). Conversely, necroptosis may be beneficial in apoptosis-resis-
tant cancer (Hanahan & Weinberg, 2011; Fulda, 2015; Brumatti
et al, 2016; Oliver Metzig et al, 2016) and to evoke an anti-tumor
immune response (Aaes et al, 2016; Krysko et al, 2017; Najafov
et al, 2017). However, too little is known about the regulatory
network controlling necroptosis to allow for predictable manipula-
tion as a therapeutic strategy (Annibaldi & Meier, 2018).
When a monoclonal cell population is challenged with a cyto-
toxic stimulus, not all cells make the decision to die at the same
time, and some cells may even survive altogether (Albeck et al,
2008; Spencer et al, 2009; Paek et al, 2016; Mitchell et al, 2018;
Green, 2019). In principle, stimulus-induced cell fate decisions may
merely be a function of the cell’s pre-existing propensity to die or to
survive. For instance, TNF-related apoptosis-inducing ligand
(TRAIL) sorts cells into survivors or non-survivors based on the
state of the molecular signaling network (Spencer et al, 2009), and
thus, the fate decision of an individual cell is predictable prior to
administering the stimulus (Loriaux & Hoffmann, 2009). Alterna-
tively, the pro-death stimulus may also trigger the de novo expres-
sion of an inhibitor of the cell fate decision. In this case, the fate
decision of an individual cell is affected by molecular stochasticity
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that governs gene induction and the interactions of pro- and anti-
death regulators, and by the dynamics of those activities. The regu-
latory motif, known as an Incoherent Feedforward Loop, is thus
known to have the capacity for differentiating the duration of the
incoming stimulus (Alon, 2007).
Tumor necrosis factor’s cytotoxic activity was initially described in
the L929 fibroblast cell line (Carswell et al, 1975) leading to the char-
acterization of necroptotic cell death (Degterev et al, 2005). TNF is
now known to first trigger the formation of signaling complex I by
recruiting receptor interacting serine/threonine kinase 1 (RIPK1) to
TNF receptor 1 (TNFR1), leading to the activation of the inhibitor κB
kinase (IKK) and transcription factor NFκB (Hoffmann & Baltimore,
2006). Dissociation of RIPK1 from the plasma membrane-bound
complex I then allows for the recruitment of RIPK3 (complex IIb or
the necrosome), which leads to RIPK3 oligomerization and phospho-
rylation of mixed lineage kinase like (pMLKL), causing plasma
membrane rupture and necroptotic cell death (He et al, 2009; Ofen-
geim & Yuan, 2013; Gong et al, 2017; Tang et al, 2019). Unlike experi-
mental cell systems that rely on co-treatment with sensitizing agents,
L929 have a natural propensity for necroptosis (Vanhaesebroeck et al,
1992; Vanlangenakker et al, 2011a), possibly due to high RIPK3
expression, and are thus an appropriate model system for studying
the regulatory network that controls TNF-mediated cell fate decisions.
Prior studies investigated NFκB as a potential necroptosis inhi-
bitor (Thapa et al, 2011; Vanlangenakker et al, 2011a; Shindo et al,
2013; Xu et al, 2018), but in certain circumstances, NFκB may even
promote necroptosis, e.g., by contributing to TNF production
(Oliver Metzig et al, 2016). Furthermore, it remains unclear whether
prior NFκB activity determines the propensity for cells to die, or
whether TNF-induced NFκB activation may determine the decision-
making, which would require de novo protein synthesis to be
induced rapidly enough to affect the activity of signaling complexes
I and II. Only the latter would constitute an incoherent feed forward
loop capable of distinguishing stimulus dynamics.
Here, we sought to determine whether and how TNF-induced
NFκB activation regulates TNF-induced necroptosis decisions. Given
the potential of perturbation studies to skew the true regulatory
network (Kreuz et al, 2001; Poukkula et al, 2005), we developed a
live-cell microscopy workflow to study unperturbed L929 cells and
obtain time-resolved quantitative necroptosis rates following TNF
exposure. A conceptual mathematical model informed us how these
death rate dynamics can be interpreted, leading us to identify TNF-
induced and NFκB-responsive TNFAIP3/A20 as a key regulator of
necroptotic fate decisions. The A20 circuit forms an incoherent feed-
forward loop to protect a fraction of cells from transient TNF doses,
but renders them sensitive to long-term TNF exposure. As predicted
by a more detailed mathematical model, dysregulated NFκB dynam-
ics diminish the cell’s ability to make necroptosis decisions based
on the duration of TNF exposure.
Results
Necroptosis kinetics are reflective of an incoherent
feedforward loop
To distinguish whether TNF-induced necroptosis decisions are
merely a function of a pre-existing propensity or the dynamics of
stimulus-induced regulators, we constructed two simple concep-
tual models. In the first, TNF induces activation of RIPK1/3 and
the necroptosis effector pMLKL, but this signaling is counteracted
by an unknown, constitutively present survival factor (Fig 1A). In
the second model, TNF also induces inhibitor of κB (IκB)-
controlled NFκB (O’Dea & Hoffmann, 2010), which in turn induces
expression of the survival factor, thus forming an incoherent feed-
forward loop (Fig 1B) (Kaern et al, 2003; Alon, 2007; Tyson &
Novak, 2010). To account for cell-to-cell heterogeneity, we
assumed stochastic gene expression (Friedman et al, 2006; Shalek
et al, 2013) of the survival factor, either constitutive or induced,
and applied a threshold for pMLKL (Gong et al, 2017; Samson
et al, 2020) corresponding to irreversible cell death (Fig 1C and D;
Appendix; Appendix Tables S1–S4).
Plotting the cell death time course by hourly binning the number
of simulations in which pMLKL exceeds the threshold, we found
that when the survival factor is pre-existing and the mechanism
constitutive, death times followed a unimodal distribution (Fig 1E).
In contrast, TNF-induced, NFκB-dependent expression of a pro-
survival factor produced a non-unimodal, apparently bimodal death
time distribution (Fig 1F). While exact death times are a function of
the particular parameters chosen in this analysis, the distinction
between unimodal vs. non-unimodal death time distributions was a
robust feature of pre-existing vs. inducible survival mechanisms
(Appendix Fig S1).
Next, we established the live-cell microscopy workflow and auto-
mated image analysis tool NECtrack to measure TNF-induced
necroptosis dynamics (Fig 1G, Movie EV1). TNF-treated L929 cells
were imaged and tracked for 24 h by nuclear Hoechst staining, and
new necroptotic death events were identified by nuclear uptake of
propidium iodide (PI) added to the culture medium. This workflow
quantified necroptosis without being confounded by concurrent cell
proliferation (Fig EV1B), a common bias of bulk readout assays
based on fractional survival (Harris et al, 2016). Average necropto-
sis rates per hour were obtained by normalizing new death events
to the number of present live cells. The use of nuclear dyes at low
concentrations had no significant effect on cell numbers (Fig EV1C).
To address the concern of phototoxicity, we compared different
counting protocols and found that the microscopy workflow actually
preserved cell viability better than a parallel, but independent count-
ing protocol that required trypsinization (Fig EV1D).
Our measurements indicated a bimodal distribution of death
times in L929 cell populations undergoing TNF-induced necroptosis
(Fig 1H), reflected by two-phased death rate dynamics (Fig 1I).
Indeed, death rates were about twofold higher in the late vs. early
(< 12 h) phase (Fig 1J) and correlated with levels of pMLKL, the
molecular marker for necroptosis (Fig 1I and EV1E and F). Similar
biphasic necroptosis kinetics were observed in a newly cloned L929
cell population treated with TNF (Fig EV1G). These experimental
results suggested that TNF does not only trigger pro-death signaling
leading to necroptosis, but also activates a mechanism that provides
for transient protection of a fraction of cells within the population.
We asked whether TNF-induced activation of NFκB RelA (Fig
EV1H and I) may be responsible. Interestingly, over a time course of
24 h, RelA activity and death dynamics were inversely correlated
(Fig EV1J). Depriving L929 cells of RelA via CRISPR/Cas9 (Fig
EV1K) led to similar fractional survival after 24 h (Fig EV1L), but
shifted necroptosis to the early phase resulting in a largely unimodal
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distribution of death times (P = 0.9, Fig 1K and L) and single-
phased death rates (Fig 1M). Increased necroptotic cell death during
the early phase was correlated with detection of pMLKL (Fig EV1M)
with most cells displaying morphological characteristics of necrotic
cell death as expected (Fig EV1N and O, Movie EV2). This sensitiz-
ing effect was even more pronounced in a clonal knockout popula-
tion (Fig 1M) that was confirmed to be fully RelA-deficient
(Fig EV1K). Together, these results support that TNF-induced RelA
is a potent inhibitor of necroptosis transiently protecting a fraction
of L929 cells from necroptosis.
Rapid induction of A20 transiently inhibits the RIPK1-RIPK3
complex and necroptosis
Next, we sought to identify the inducible mechanism by which RelA
transiently protects a fraction of L929 cells from necroptosis. NFκB-
induced gene products may limit necroptosis by inhibiting reactive
oxygen species (ROS) production or pro-death c-Jun N-terminal
kinase (JNK) signaling (Sakon et al, 2003; Kamata et al, 2005;
Shindo et al, 2013; Zhang et al, 2017; Yang et al, 2018). While TNF-
induced generation of ROS may amplify necroptosis signaling
(Vanlangenakker et al, 2011b), addition of the anti-oxidant buty-
lated hydroxyanisole (BHA; Fig EV2A), or the specific JNK inhibitor
SP600125 (Fig EV2B) had limited effect in RelA-knockout cells. This
suggested that RelA-mediated inhibition of necroptosis was not criti-
cally mediated by ROS or JNK.
Several potential NFκB-responsive target genes have been
described to modulate TNFR-induced complex I, complex II, and/or
the necrosome (Vanlangenakker et al, 2011a; Dondelinger et al,
2016). In complex IIa, FLIP-L has been implicated in restricting the
proteolytic activity of pro-caspase-8 and directing its substrate speci-
ficity toward RIPK1 to disassemble the RIPK1-RIPK3-complex and
inhibit necroptosis (Oberst et al, 2011; Tsuchiya et al, 2015; Hughes
et al, 2016; Newton et al, 2019). In line with this, pre-treatment with
the pan-caspase inhibitor ZVAD accelerated TNF-induced necropto-
sis rates (Fig EV2C). However, FLIP-L mRNA was not induced by
TNF in L929 cells (Fig EV2D), and similar dynamics of FLIP-L cleav-
age were observed in wild-type and RelA-knockout cells (Fig EV2E),
indicative of comparable proteolytic activity of pro-caspase 8 in
complex II (Yu et al, 2009; Tsuchiya et al, 2015). Similarly, mRNA
levels of CYLD or cIAP1, which are involved in the regulation of
complex I activity (Annibaldi & Meier, 2018), were not significantly
induced by TNF or reduced in RelA-knockout cells (Fig 2A). In
contrast, TNFAIP3/A20 and cIAP2 were significantly induced within
0.5 or 1 h of TNF treatment in a RelA-dependent manner (Fig 2A),
whereas only A20 expression was transient and correlated with
dynamics of RelA activity (Fig EV2F). Inducible mRNA expression
was accompanied by elevated A20 protein detected after 2 h of TNF
treatment in wild-type, but not RelA-knockout cells, while constitu-
tive expression levels were not significantly affected (Fig EV2G).
Thus, inducible A20 appeared to be a promising candidate to medi-
ate RelA-dependent transient protection from necroptosis.
Several A20-dependent mechanisms to limit TNF-induced cell
death have previously been reported (Draber et al, 2015; Onizawa
et al, 2015; Polykratis et al, 2019; Martens et al, 2020; Razani et al,
2020). In complex I, A20 binds and stabilizes M1-ubiquitin chains,
which may limit formation of death-inducing complex II (Draber
et al, 2015; Polykratis et al, 2019; Martens et al, 2020; Razani et al,
2020). In addition, A20 integrates into the downstream necrosome
and restricts RIPK3 activation to limit necroptosis (Onizawa et al,
2015). Whereas complex I forms rapidly (Micheau & Tschopp,
2003), the necrosome is activated slower (Vanlangenakker et al,
2011a), potentially allowing de novo expressed A20 to interfere with
its activity. Indeed, we found that inducible expression of A20
coincided with its increased dynamic integration into RIPK3
immuno-precipitates at 2 and 4.5 h in wild-type compared with
RelA-knockout cells (Fig 2B and C). This was accompanied by
decreased binding of RIPK1 in wild-type cells (Fig 2B), indicating
destabilization of the necrosome (Onizawa et al, 2015). Similar
levels of phosphorylated RIPK1 (Ser166; Fig EV2H) and cleaved
FLIP-L (Fig EV2E) were detected in wild-type and RelA-knockout
cells, indicating that complex I and II activities (Yu et al, 2009;
Dondelinger et al, 2015; Tsuchiya et al, 2015; Dondelinger et al,
2017; Laurien et al, 2020) were less affected by inducible A20.
As biphasic necroptosis kinetics had indicated that the RelA-
dependent survival mechanism only protected a fraction of cells
from premature necroptosis, we asked whether cell-to-cell hetero-
geneity in TNF-induced A20 expression may be responsible. Analyz-
ing TNF-induced gene expression in single cells via smFISH
revealed that A20 mRNA was only upregulated in 76% and 75% of
◀ Figure 1. Necroptosis kinetics are reflective of an incoherent feedforward loop.A, B Conceptual mathematical modeling schematics depict TNF-induced necroptosis signaling via RIPK1/3 (RIP) and phosphorylation of MLKL (pMLKL). RIP is
counteracted by a putative (A) constitutive, or (B) stimulus-induced, NFκB-dependent survival factor X.
C, D Time course simulations of pMLKL levels in 300 single cells where each trajectory crossing a threshold represents a cell death event. Simulations for (C)
constitutive, or (D) stimulus-induced survival mechanism.
E, F Distributions of death times that result from simulations in (C, D), respectively. Fractional survival indicated after 24-h time course simulation.
G Live-cell microscopy workflow and automated image analysis via NECtrack to quantify TNF-induced necroptosis kinetics in L929 cells. Distributions of death times
and death rates are computed from raw counts of live and dead cells based on nuclear propidium iodide (PI) staining.
H Distribution of death times in TNF-treated L929 wild-type (wt) cells (representative data of three independent experiments).
I Normalized death rates in L929 wt cells plotted with pMLKL protein levels measured via immunoblot (mean of three independent experiments  standard
deviation; corresponding images of representative Western blot experiment in Fig EV1F).
J Average death rates of the early (< 12 h) and late phase of the TNF time course data in (I) (mean of three independent experiments  standard deviation; two-
tailed Student’s t-test ***P < 0.001).
K Distribution of death times in L929 RelA-knockout (RelA KO) cells treated with TNF (representative data of three independent experiments).
L Probability of unimodal distributions of death times calculated by Hartigan’s dip significance (mean of three independent experiments  standard deviation; two-
sample t-test **P < 0.01).
M Death rates in TNF-treated cell lines including clonal RelA-knockout population (mean of three independent experiments  standard deviation).
Source data are available online for this figure.
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“responder” cells at 0.5 and 1 h, respectively, whereas the NFκB-
responsive target IκBα was induced in nearly all cells (Figs 2D and
E, and EV2I and J). In fact, the fraction of “responder” cells coarsely
correlated with fractional survival after the early phase of TNF
treatment (Fig 2F).
To further confirm the functional requirement of inducible A20,
we performed siRNA-mediated knockdown of A20. Knockdown
conditions were optimized to significantly decrease TNF-induced
expression of the A20 mRNA (Fig 2G), but—due to protein half-life
—without having a significant effect on basal A20 protein levels
present at the start of the TNF stimulation (Fig 2H). These condi-
tions strongly sensitized L929 wild-type cells to TNF leading to the
majority of cells dying during the early phase, which resulted in
unimodal death time distributions (Fig 2I) and single-phased death
rate dynamics comparable to RelA-knockout cells (Fig 2J). In
contrast, loss of cIAP2 (Fig EV2K and L) had no significant effect on
necroptosis rates (Fig EV2M), which was in line with previous find-
ings (Vanlangenakker et al, 2011b).
Together, our results indicated that following TNF-induced, RelA-
responsive A20 expression in a subset of cells, A20 binds to and
subsequently inhibits RIPK1-RIPK3 complexes, thereby transiently
protecting these cells from necroptosis. However, as RelA activity and
A20 expression subside, these cells may become sensitive again and
undergo necroptosis in the later phase of the time course.
The NFκB-A20-RIPK3 incoherent feedforward loop discriminates
TNF stimulus dynamics
To further investigate the crosstalk between TNF-induced NFκB and
necroptosis fate decisions, we constructed a mathematical model
that integrates the diverse roles of A20 in NFκB activation and
necroptosis control (Fig 3A) (Lee et al, 2000; Werner et al, 2008;
Harhaj & Dixit, 2012; Draber et al, 2015; Onizawa et al, 2015;
Polykratis et al, 2019; Martens et al, 2020; Razani et al, 2020; Sun,
2020). The model consists of 41 species and 98 reactions (Fig EV3A,
Appendix, Appendix Tables S5–S9) and combines the previously
published modules for TNFR-IKK and IκB-NFκB signaling (Werner
et al, 2008; Shih et al, 2009) with a newly constructed necroptosis
module depicting activation of RIPK1, RIPK3, and the effector
pMLKL. We parameterized the model based on literature and to fit
our experimental measurements in L929 cells (Appendix). Simula-
tion of 24 h of TNF treatment accurately recapitulated measure-
ments of A20 expression at the mRNA and protein level (Fig EV3B
and C), NFκB activation (Fig EV3D), and necrosome activity
(Fig EV3E–G) (Li et al, 2012). Accounting for cell-to-cell heterogene-
ity in A20 expression as measured in smFISH experiments, as well
as in RIPK1 activation (Appendix), we tested whether the model
also recapitulated necroptosis kinetics in TNF-treated L929 cell
populations, and the NFκB-dependent regulation. Indeed, simula-
tions of wild-type (Fig 3B) or RelA-knockout cell populations (Fig 3
C) showed the distinctive bimodal vs. unimodal distributions of
death times as well as the two- vs. single-phased death rates, respec-
tively, that we had observed in experiments. These results provided
quantitative support to the notion that TNF-induced, RelA-mediated
expression of A20 provides transient protection from necroptosis.
Previous work demonstrated that while A20 plays a key role in
modulating NFκB dynamics, its NFκB-inducible expression does not
(Werner et al, 2008). We wondered if the inducibility of A20 was
instead required to provide proper dynamic regulation of TNF-
induced cell death decisions. We employed the mathematical model,
set the inducible expression of A20 to zero, and simulated 24 h of
TNF treatment with different levels of only constitutive A20 expres-
sion. While constitutively elevated A20 expression (twofold or four-
fold) protected from death, two-phased necroptosis dynamics as
characteristic in wild-type cells were not predicted (Fig 3D). To test
this experimentally, we expressed A20 from a constitutive transgene
in RelA-knockout cells, which led to 2.5-fold increased basal expres-
sion (Fig EV3H). Indeed, death dynamics remained unimodal
(Figs 3E and EV3I), although cells were protected from necroptosis
compared with RelA-knockout cells (Fig 3F). However, when we
reconstituted L929 A20-knockout cells (Fig EV3J) with an NFκB-
inducible transgene (Fig EV3K), two-phased necroptosis dynamics
were restored (Figs 3G and H, and EV3L). These results indicated
that the TNF-inducible RelA-A20-RIPK3 circuit motif plays a critical
role in shaping necroptotic death kinetics.
While in physiological settings TNF is typically secreted in tran-
sient bursts to coordinate and resolve inflammation, prolonged
secretion and elevated levels of TNF are associated with
◀ Figure 2. Rapid induction of A20 transiently inhibits the RIPK1-RIPK3 complex and necroptosis.A TNF-induced mRNA expression in L929 wild-type (wt), or RelA-knockout (RelA KO) cells measured via qRT–PCR (mean of three independent experiments  standard
deviation, two-tailed Student’s t-test *P < 0.05, **P < 0.01).
B Immunoblot after co-immunoprecipitation (IP) of RIPK3 in indicated cell lines. FT, flow through.
C Relative quantification of A20 in RIPK3-IP fraction in (B) (means and statistical significance established for 0, 2, 4.5, and 8 h time points from three independent
experiments  standard deviation; two-tailed Student’s t-test *P < 0.05, **P < 0.01, n.s., P > 0.05).
D Histogram of volume normalized mRNA copy numbers measured by smFISH of NFκB target genes A20 and IκBα in L929 wt cells treated with TNF (representative
data of three independent experiments; two additional independent experiments in Fig EV4H).
E Fractions of “responder” cells in (D) and Fig EV4H (A20 count > 1 per cell; mean of all three independent experiments  standard deviation).
F Fractional survival of wt cells after the early (< 12 h) and late phase of TNF time course obtained by microscopy (mean of three independent experiments  standard
deviation).
G A20 mRNA expression via qRT–PCR in TNF-treated wt cells transfected with targeting (siA20) or non-targeting (siCon) siRNA (mean of three independent
experiments  standard deviation; two-tailed Student’s t-test *P < 0.05).
H Immunoblot and relative quantification of basal A20 protein after siRNA-knockdown normalized to non-targeting siRNA control (mean of three independent
experiments  standard deviation; two-tailed Student’s t-test revealed no statistically significant difference between targeting and non-targeting siRNA treatment,
n.s., P > 0.05).
I, J (I) TNF-induced distributions of death times (representative data of three independent experiments) and (J) death rates obtained by live-cell microscopy (mean of
three independent experiments  standard deviation).
Source data are available online for this figure.
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autoimmune and chronic inflammatory diseases (Beutler et al,
1985b; Agbanoma et al, 2012; Wallach & Kovalenko, 2016). We
hypothesized that the inducible RelA-A20-RIPK3 circuit may deter-
mine the fractional survival of cells in response to transient TNF
stimulation, while leaving cells sensitive to long-lasting TNF expo-
sures. Model simulations testing a range of different temporal TNF
doses (3–12 h, Appendix) predicted that L929 wild-type cells would
indeed be better protected from transient TNF exposures than RelA-
knockout cells, while remaining sensitive when exposed to long-
lasting TNF stimulation (Fig 3I). Experiments confirmed that wild-
type, but not RelA-knockout populations, were able to discriminate
short-term exposures of up to 12 h from sustained 24-h TNF treat-
ment (Fig 3J). However, wild-type and RelA-knockout cells
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EV3M), suggesting that the primary role of the RelA-A20-RIPK3
circuit motif is to discriminate between transient and sustained
TNF, rather than concentration doses.
Dysregulated NFκB dynamics diminish the cellular discrimination
of TNF exposures
As dysregulated NFκB activity is often associated with disease
(Hanahan & Weinberg, 2011; Taniguchi & Karin, 2018), we utilized
our mathematical model to explore necroptosis fate decisions as a
function of altered RelA dynamics. To this end, we defined NFκB
dynamics with an extrinsic pulse function rather than the normal
IκB-circuit (Appendix). The model predicted that prolonged NFκB
dynamics and A20 expression (Fig 4A) led to increased fractional
survival in 24-h simulations of TNF treatment (Fig 4B). To experi-
mentally test this scenario, we targeted the IκB regulatory system via
CRISPR/Cas9-mediated gene knockout (Fig 4C), resulting in signifi-
cantly prolonged TNF-induced RelA activity (Figs 4D, and EV4A and
B), as well as prolonged expression of A20 mRNA and protein, while
basal expression was unchanged (Fig 4E and F). As expected, IκBα/
IκBϵ-knockout cells were more resistant to TNF-induced necroptosis
with significantly increased fractional survival of 67% (Fig 4G) simi-
lar to the model prediction (56%, Fig 4B), and overall decreased
death rates in response to 24 h of sustained TNF treatment (Fig 4H).
This effect was even more pronounced in a clonal population
selected for IκBα/IκBϵ-knockout and CRISPR/Cas9-induced heterozy-
gosity for p100 to compensate for upregulated IκB δ inhibitory activ-
ity (O’Dea & Hoffmann, 2010), while maintaining wildtype-like basal
A20 expression (Figs 4H and EV4C). Finally, siRNA-mediated knock-
down targeting A20 in IκBα/IκBϵ-knockout cells confirmed that the
protective effect was largely due to A20, as death rates now resem-
bled those of wild-type cells treated with siA20 treatment (Fig 4I).
Together, these data implicate that in conditions of dysregulated
NFκB dynamics and prolonged expression of A20, cells are more
likely to resist even long-lasting TNF exposures.
Discussion
In this study, we have addressed the regulatory mechanisms that
determine TNF’s dual roles in inflammation, namely whether TNF
elicits a cellular response that includes coordination and resolution
of the inflammatory condition, or necroptotic cell death that may
further amplify inflammation. Using time-lapse microscopy, we
identified an incoherent feedforward loop involving TNF-induced
NFκB/RelA activity and de novo expressed A20 protein, which
provides potent, though transient protection to RIPK3-mediated
necroptosis. We demonstrated that this molecular circuit ensures
that a majority of cells survive transient TNF exposures, but,
because of the transience of A20 expression, does not protect from
long-lasting TNF exposure.
While a potential role of NFκB in inhibiting necroptosis was
previously suggested (Thapa et al, 2011; Shindo et al, 2013; Xu
et al, 2018), the molecular regulatory circuits and its significance for
necroptosis decision-making remained unknown. Although the anti-
inflammatory protein A20 is a prominent NFκB-response gene, its
robust TNF-inducibility is not required for inhibiting NFκB (Werner
et al, 2008), prompting the question of why A20 expression is so
highly TNF-inducible. Here, we demonstrate that TNF-inducible
A20 is in fact key to linking NFκB and the regulation of necroptosis
decisions. Even under conditions of exceptional TNF sensitivity as
demonstrated in the L929 cell model system, NFκB-responsive A20
provides potent, though transient protection from necroptosis,
which is critically determined by the duration of induced A20
expression and TNF exposure times. The A20 expression time
course is controlled by NFκB dynamics, which is in turn a function
of stimulus duration and IκB feedback regulation (Werner et al,
2008; Lane et al, 2017). We found that when cells are deprived of
negative feedback mechanisms that ensure physiological NFκB
dynamics, subsequent prolonged expression of A20 will diminish
TNF-induced necroptosis.
Previous studies established A20 as an inhibitor of TNF-induced
cell death (Lee et al, 2000; Draber et al, 2015; Onizawa et al, 2015;
Polykratis et al, 2019; Martens et al, 2020; Razani et al, 2020). Via
its ubiquitin-binding domain ZnF7, A20 is believed to stabilize M1-
linked ubiquitin chains in TNFR1-induced complex I, which may
restrict complex II formation and thereby apoptosis and/or necrop-
tosis as shown in MEFs (Draber et al, 2015), macrophages (Poly-
kratis et al, 2019), and intestinal epithelial cells (Martens et al,
2020). In addition, previous work in T cells and MEFs suggested
that A20 binds to the necrosome, which may also be mediated via
its ZnF7 domain, to enable ubiquitin editing and disruption of
◀ Figure 3. The NFκB-A20-RIPK3 incoherent feedforward loop discriminates TNF stimulus dynamics.A Modeling schematics depict TNF-induced activation (*) of complex I (C1) and IKK to induce transcriptional activity of NFκB. C1 can also initiate activation of RIPK1
and RIPK3 to induce phosphorylation of necroptosis executor MLKL (pMLKL). TNF-induced expression of IκB attenuates NFκB, whereas A20 inhibits IKK and RIPK3.
B, C Computational simulations and microscopy analysis of death time distributions (left, representative data of three independent experiments) and death rates (right,
mean of three independent experiments  standard deviation) in TNF-treated L929 (B) wild-type (wt), or (C) RelA-knockout (KO) cells.
D Simulated death time distributions with twofold or fourfold increased constitutive A20 expression in the absence of inducible transcription (300 simulated cells per
condition).
E Death time distributions in TNF-treated parental RelA KO cells (−) or RelA KO cells expressing A20 from a constitutive transgene (pBabe-A20, +, representative data
of three independent experiments).
F Average death rates (< 12 h) in TNF-treated cells (mean of three independent experiments  standard deviation; two-tailed Student’s t-test *P < 0.05, or no
statistically significant difference, n.s., P > 0.05).
G, H (G) Distribution of death times (representative data of three independent experiments), or (H) death rates in TNF-treated wt, parental A20 KO cells, or A20 KO cells
reconstituted with an NFκB-inducible transgene (fIL8-A20; mean of three independent experiments  standard deviation).
I, J (I) Simulations and (J) experimental measurements of 24-h fractional survival after varying durations of transient or sustained (24 h) TNF stimulation (mean of
three independent experiments  standard deviation; two-tailed Student’s t-test ***P < 0.001, or no statistically significant difference, n.s., P > 0.05).
Source data are available online for this figure.
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RIPK1-RIPK3-complexes (Onizawa et al, 2015; Dondelinger et al,
2016). Our iterative approach of mathematical modeling and experi-
ments provides a refined, quantitative, and dynamic picture of
A20’s roles in determining TNF-mediated fate decisions. We show
that inducible A20 expression kinetics shape the dynamics of TNF-
induced necroptosis decisions. As upstream complex I is activated
rapidly within minutes of TNF stimulation (Micheau & Tschopp,
2003), we reason that constitutively (but not induced) expressed
A20 may integrate and limit the rate of transitioning into
death-inducing complex II (Priem et al, 2019) to determine both the
apoptotic and necroptotic propensity. The active necrosome,
however, forms only within hours (Vanlangenakker et al, 2011a;
Vanlangenakker et al, 2011b) and is therefore more susceptible to
inducibly expressed A20, which is why NFκB activity dynamics and
the duration of the stimulus may be more critical in shaping necrop-
tosis decisions. Indeed, our biochemical analyses showed that A20
expression kinetics coincided with its dynamic integration into






Figure 4. Dysregulated NFκB dynamics diminish the cellular discrimination of TNF exposures.
A Simulations of A20 mRNA concentrations in versions of the NFκB-necroptosis model where expression is under the control of synthetic NFκB activity following step
functions of 0.5, 1, 2, 4, 8, or 16 h duration (smoothed line is population average, and shaded area the 30th percentile around the median).
B Fractional survival that results from simulations in (A).
C Immunoblot for IκBα and IκBϵ in L929 wild-type (wt) and CRISPR/Cas9-knockout cell lines. Asterisks depict unspecific bands.
D Normalized RelA activity dynamics after TNF treatment quantified via EMSA (mean of three independent experiments  standard deviation; two-tailed Student’s t-
test *P < 0.05, **P < 0.01; corresponding images of representative experiment in Fig EV4A).
E A20 mRNA quantified via qPCR (mean of three independent experiments  standard deviation; two-tailed Student’s t-test *P < 0.05).
F Immunoblot for A20 (representative data of three independent experiments).
G Fractional survival after 24 h of TNF treatment in indicated cell lines (mean of three independent experiments  standard deviation; two-tailed Student’s t-test
**P < 0.01).
H Death rates in TNF-treated indicated cell lines including isogenic IκBα/IκBϵ-knockout population (mean of three independent experiments  standard deviation).
I Death rates in TNF-treated cell lines treated with targeting (siA20) or non-targeting (siCon) siRNA (mean of three independent experiments  standard deviation).
Source data are available online for this figure.
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distinct molecular mechanisms ascribed to A20 in complex I/II
contribute to necroptotic and apoptotic death decisions. The regula-
tory principles identified here put A20 into a position to limit
necroptosis: When RIPK3 activation is slowed, but not blocked by
low Caspase 8 activity, there is sufficient time for induced A20 to
provide transient protection to cells from necroptotic death. In this
scenario, the dynamics (transience/duration) of the two branches of
the incoherent feedforward loop determine the cell fate decision of
necroptosis vs. survival. This insight provides a guide on how to
interpret studies on necroptosis vs. survival decisions in other cell
types or experimental systems, which require inhibition of caspases
to undergo necroptosis.
NFκB also protects cells from apoptosis, as genetic and pharma-
cologic perturbation studies revealed (Beg et al, 1995; Micheau &
Tschopp, 2003) by contributing to the expression of anti-apoptotic
target genes such as caspase inhibitor cFLIP (Micheau et al, 2001).
However, these studies do not demonstrate that apoptosis deci-
sions are regulated by TNF-induced gene expression (Beg et al,
1995; Micheau & Tschopp, 2003). While protein synthesis inhibi-
tors sensitize cells to TNF-induced apoptosis (Micheau et al,
2001), they also block constitutive protein expression, including
key anti-apoptotic target genes such as cFLIP, whose short half-life
requires continuous constitutive synthesis (Kreuz et al, 2001;
Poukkula et al, 2005). Of note, cFLIP is only weakly induced by
TNF (Kreuz et al, 2001; Micheau et al, 2001). The fact that TNF
pulses as short as 30 s may be as effective as continuous exposure
in eliciting apoptotic responses (Lee et al, 2016) may suggest that
the stimulus itself merely sorts cells by a pre-existing apoptotic
propensity, which may in turn be affected by the level of tonic
NFκB activity (Lin et al, 1998; Loriaux & Hoffmann, 2009; Gaudet
et al, 2012).
What might be the physiological consequences of the differential
regulatory strategies by which NFκB controls apoptosis and
necroptosis? A cell’s decision to undergo apoptosis appears to be
inherent, depending on the general health of a cell, tonic NFκB, and
hence its history of having responded appropriately to prior
inflammatory conditions. If cells are unhealthy, they will be weeded
out via apoptosis without causing much inflammation. In contrast,
whether cells that express the necroptosis machinery will die of
necroptosis is also a function of the dynamics of NFκB and duration
of the TNF signal (Fig EV5A). Healthy NFκB activity dynamics in
response to physiological TNF doses will ensure these cells partici-
pate in immune modulatory tissue processes rather than die.
However, if TNF doses last longer, as they may in persistent infec-
tions, sepsis or chronic inflammatory diseases, cells may die via
necroptosis and thereby release DAMPs to fuel an overwhelming
inflammatory response (Fig EV5A). Indeed, loss of Caspase-8 (Gun-
ther et al, 2011) or FADD (Welz et al, 2011) induces TNF-mediated
necroptosis and inflammatory lesions in murine intestinal epithelium,
resembling the pathology of inflammatory bowel disease. In turn, loss
of MLKL or RIPK3 protected mice from TNF-induced systemic
inflammatory response syndrome (SIRS) (Newton et al, 2016). Two
recent reports further pointed out that A20’s anti-inflammatory prop-
erties are not solely reliant on inhibiting IKK/NFκB, but depend on
the prevention of TNF-induced cell death (Polykratis et al, 2019;
Martens et al, 2020). In this context, our work establishes physiologi-
cal NFκB dynamics as a safeguard against overwhelming inflamma-
tion, namely by securing physiological expression of A20 and
therefore protecting from TNF-induced necroptosis.
In contrast, in tumors amplifying inflammatory responses via
necroptotic cell death may have beneficial effects, increasing
immunogenicity and helping to establish effective anti-tumor immu-
nity (Fig EV5B). In this context, sensitizing cells to TNF or other
necroptotic stimuli by counteracting inducible NFκB or the protec-
tive functions of A20 may have potential therapeutic value to
enhance anti-tumor immunity.
Materials and Methods
Reagents and Tools table
Reagents/resource Reference or source Identifier or catalog number
Experimental Models




lentiCRISPR v2 Addgene Cat # 52961
pBabe-A20 Werner et al (2008)
fIL8-A20 Lois et al (2002), Werner et al (2008)
Antibodies
Rabbit monoclonal [EPR9515(2)] to MLKL (phospho S345) Abcam Cat # ab196436
Mouse anti-RIP BD Biosciences Cat # 610459
Rabbit Phospho-RIP (Ser166) Antibody Cell Signaling Cat # 31122S
Rabbit anti-RIP3 Sigma Aldrich Cat # PRS2283
Rabbit NFκB p65 Antibody (C-20) Santa Cruz Cat # sc-372
Rabbit RelB Antibody (C-19) Santa Cruz Cat # sc-226
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Reagents and Tools table (continued)
Reagents/resource Reference or source Identifier or catalog number
Rabbit IκB-α Antibody (C-21) Santa Cruz Cat # sc-371
Rabbit IκB-β Antibody (C-20) Santa Cruz Cat # sc-945
Rabbit IκB-ϵ Antibody (M-121) Santa Cruz Cat # sc-7156
Rabbit p52/100 (NR-145) generous gift from Nancy Rice
Mouse A20 Antibody (A-12) Santa Cruz Cat # sc-166692
Rat FLIP Antibody [Dave-2] ProSci Cat # XA-1008
Mouse cIAP Pan-specific Antibody R&D Cat # MAB3400
Rat c-IAP1 monoclonal antibody (1E1-1-10) Enzo Life Sciences Cat # ALX-803-335
Oligonucleotides and sequence-based reagents
qPCR primers This study Table EV1
Oigonucleotides for smFISH This study Table EV2
gRNAs for CRISPR/Cas9 This study Table EV3
non-targeting siRNA control Dharmacon Cat # D-001206-13
A20 siRNA Dharmacon Cat # M-058907
pBabe-A20 Werner et al (2008)
fIL8-A20 Lois et al (2002), Werner et al (2008)
Chemicals, enzymes and other reagents
Mouse recombinant TNF R&D Cat # 410-MT-10
Propidium iodide (PI) Sigma Aldrich Cat # P4864
Hoechst 33342 Thermo Fisher Scientific Cat # H21492
ZVAD-fmk Enzo Life Sciences Cat # BML-P416-0001
Necrostatin-1 Enzo Life Sciences Cat # BML-AP309
Butylated hydroxyanisole (BHA, ROS inhibitor) Sigma Aldrich Cat # B1253
SP600125 (JNK inhibitor) Sigma Aldrich Cat # S5567
Direct-zol RNA Miniprep Plus Kit Zymogen Cat # R2071
iScript cDNA Synthesis Kit Bio-Rad Cat # 1708890
SYBR Green PCR Master Mix Bio-Rad Cat # 1725150
Quick-DNA Miniprep Plus Zymogen Cat # D4068
DharmaFECT1 Dharmacon Cat # T-2001-01
Software
MATLAB R2015b (Version 8.6.0.267246)
Image Lab (Version 5.2 build 14) Bio-Rad
Zen2 (blue edition, Version 2.0.0.0) Carl Zeiss Microscopy GmbH
Gen5 (Version 1.11.5) Bio-Tek Instruments
CFX Maestro 1.1 (Version 4.1.2433.1219) Bio-Rad
ImageQuant TL, 1D (Version 7.0) GE Healthcare
Other
AxioObserver Carl Zeiss Microscopy GmbH
CoolSnap HQ2 camera Photometrics
Epoch microplate reader BioTek
ChemiDoc MP imaging system BioRad
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Methods and Protocols
Cell culture
L929 cells were maintained in DMEM (Corning) containing 10%
FBS (Omega Scientific), 1% L-Glutamine, and 1% penicillin/strepto-
mycin (Thermo Fisher Scientific) at 5% CO2 and 37°C. Isogenic
L929 wild-type or CRISPR/Cas9-modified cell lines (RelA- or IκBα/
IκBϵ-knockout) were established by single-cell sorting and clonal
expansion as indicated.
Live-cell microscopy and image analysis
• Seed L929 cells (3 × 105) into eight-well μ-slides (ibidi) and grow
for 24 h.
• Immediately before experiment, add Hoechst (15 ng/ml) to
culture medium and stain cells in incubator for 20 min.
• Remove Hoechst containing medium and add culture medium
containing propidium iodide (1 μg/ml), and TNF (10 ng/ml).
• Transfer dish to Zeiss AxioObserver equipped with an incubation
chamber, a 20× objective, LED (light-emitting diode) fluorescence
excitation, and CoolSnap HQ2 camera. Equilibrate for 30 min at
5% CO2 and 37°C.
• Set imaging positions and image differential interference contrast
(DIC), Hoechst (excitation at 365 nm, Zeiss Filter Set 49), and PI (ex-
citation at 587 nm, Semrock mCherry B-000) every 1.5 min for 24 h.
• Export TIFF images for automated analysis using MATLAB.
Our automated image analysis tool NECtrack identifies, segments
and tracks individual cells based on DIC and Hoechst images (Selim-
khanov et al, 2014), and measures their mean nuclear PI intensity
over time. Cells were declared dead when numerical threshold of
nuclear PI was crossed for at least six consecutive time frames, and
first frame was stored to generate histogram of death times. The
status of each cell per frame was then integrated into a single binary
matrix with cells and time points in rows and columns, respectively,
with 0 representing “alive” and 1 indicating death had occurred.
Absolute numbers of death events were converted to a rate of cell
death proportional to the number of cells alive at a time point by
using a 5-h sliding window, in which the number of new death
events within a window was divided by the number of cells alive at
the beginning of the window. The death rate at a time point is there-
fore the rate of death that will occur over the following 5 h for cells
alive at that time point; this accounts for continuous numerical
changes in the population, e.g., by cell death or division. Average
death rates per hour, i.e., the probability for individual cells to die
within a given time window, is reported as the mean percentage of
three independent experiments  standard deviations until remain-
ing alive cell population drops under one third of the starting popu-
lation (approx. 250–300 cells per experiment and condition). To
obtain proliferative index, cell divisions were manually counted per
4-h time window and normalized to the number of alive cells
present at the beginning of each window.
Statistical analysis of distributions of death times
All death times were placed into a single-ordered array and passed to
MATLAB’s “histcounts” function with “Normalization” set to “pdf”
and histogram bins defined every 2 h from 30 min (first time point)
to 24.5 h (final time point). The calculated probability distribution of
cell death was plotted as a histogram. The null hypothesis that the
sorted array of death times was drawn from a unimodal distribution
was tested by Hartigan’s dip significance test for unimodality, which
calculates a probability of unimodality (Hartigan, 1985). This was
repeated for three independent experiments for TNF-treated wild-
type or RelA-knockout cells. The probabilities of unimodality in each
condition were compared with a two-sample t-test.
Cell viability endpoint assays
Crystal violet assay:
• Grow 1 × 104 cells per well in 96-well plates for 24 h.
• Add drugs (ZVAD: 30 μM, BHA: 50 μM, or JNK inhibitor: 10 μM)
for 1 h as indicated, prior to TNF (10 ng/ml) treatment.
• For pulse stimulation experiments, treat cells with TNF for the
indicated durations, wash, and then incubate in culture medium
before taking 24-h endpoint measurements.
• At endpoint, stain cells with crystal violet staining solution (0.5%
in 20% methanol) for 10 min.
• Wash plates with water, add sodium citrate solution (0.1 M in
50% ethanol) to dry wells and measure absorption using a micro-
plate reader. Normalize data to mock-treated controls.
Manual cell counting:
• Grow 6 × 105 cells per well were grown in six-well plates for
24 h.
• Treat with TNF (10 ng/ml) for indicated durations.
• Detach cells with trypsin resuspend in culture medium and count
alive cells using a hemocytometer and Trypan blue exclusion
staining.
Immunoblotting
• Grow 2–3 × 106 cells in 10-cm plates for 24 h and add treatments
as indicated.
• Remove dead cells by thoroughly washing with PBS, harvest
remaining adherent cells, and lyse using RIPA buffer containing
1% Triton X-100 supplemented with PMSF, DTT, and phos-
phatase inhibitors.
• Normalize samples for total protein amounts using a Bradford
assay (Bio-Rad).
• Boil detergent insoluble fractions for 10 min in 3× SDS sample
buffer and subject to gel electrophoresis and immunoblotting.
• Incubate with respective antibodies and develop signal using
chemiluminescent substrate (SuperSignal West Pico Plus, Thermo
Fisher Scientific). Visualize and quantify bands using ChemiDoc
MP imaging system (Bio-Rad).
Co-immunoprecipitation (Co-IP)
• Grow 6 × 106 cells in 15-cm plates for 24 h.
• Wash with PBS and lyse on ice in 30 mM Tris–HCL pH 7.4,
150 mM NaCl, 10% glycerol, 2 mM EDTA, 0.5% Triton, 0.5%
NP-40, 1 mM DTT containing de-ubiquitinase inhibitor PR-619,
protease and phosphatase inhibitors.
• Normalize lysates for total protein amounts and incubate with
anti-RIPK3 (1 μg antibody per 1 mg protein) for 4 h at 4°C.
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• Add protein G beads (Dynabeads, Thermo Fisher Scientific) for
1 h to isolate complexes and wash five times in Co-IP lysis buffer.
• If indicated, subject flow through to secondary co-immunoprecipi-
tation with anti-RIPK1 (1 μg antibody per 1 mg protein; incubate
overnight at 4°C).
• Boil IP fraction, flow through, and input lysates in 1× or 3× SDS
sample buffer and subject to immunoblotting.
Electrophoretic mobility shift assay (EMSA)
For gel-shift assays, nuclear extracts (Basak et al, 2007; Schrofel-
bauer et al, 2012) were incubated with 32P-labeled, double-stranded
DNA probes containing kB-binding sites in the presence or absence
of anti-RelA or anti-RelB, prior to nondenaturing acrylamide gel
electrophoresis. Bands were visualized by autoradiography and
quantified using ImageQuant software.
Quantitative real-time PCR (qRT–PCR)
RNA was purified using Direct-zol RNA Miniprep Plus Kit (Zymo-
gen), and cDNA synthesized with iScript cDNA Synthesis Kit (Bio-
Rad). qRT–PCR was performed with SYBR Green PCR Master Mix
reagent using the D(DCt) method with RPL as normalization
control, relative to unstimulated and stimulated signals in L929 cells
to derive fold induction (Table EV1).
Single-molecule fluorescence in situ hybridization (smFISH) and
image analysis
• Design oligos (50 bp) using custom software developed by the
Zhuang laboratory for MERFISH (Moffitt et al, 2016). Oligos in
this study were comprised of a 30-bp region complementary to
A20 or IκBα, and a 20-bp mouse orthogonal sequence that binds
to dye-labeled “readout oligo”. 52 different gene targeting regions
were selected to tile along the length of the transcripts of interest
(Table EV2). Dye-labeled oligos used Cy5 and Atto 565, respec-
tively, to image labeled transcripts as diffraction limited spots.
• Plate cells (3 × 105) in eight-well μ-slides (ibidi), grow for 24 h,
and stimulate with 10 ng/ml TNF for different durations.
• Remove medium and fix with 4% paraformaldehyde in PBS
buffer.
• Rinse with PBS and permeabilize cells with 0.5% v/v Triton X-
100 in PBS, followed by 3× rinse with Tris-buffered 300mM NaCl
supplemented with 0.1% Tween-20 (TBS2Xtw).
• Equilibrate for 10 min in TBS2Xtw supplemented with 30%
formamide (MW), aspirate liquid, and add TBS2Xtw supple-
mented with 30% formamide and 10% dextran sulfate.
• Hybridize with 50 nM oligo mixture for both A20 and IκBα over-
night (16 h) at 37°C.
• Wash 2× with MW at 47°C for 30 min, and hybridize with a PER
amplifier oligo at 25 nM concentration in MH for 30 min at room
temperature (Kishi et al, 2019)
• Wash and stain for nuclei with DAPI, and stain with readout oligo
in TB2XStw supplemented with 10% ethylene carbonate for
30 min, before washing with the same solution without readout
oligo.
• Add imaging buffer (4 mM PCA and 0.3 U/ml of rPCO oxygen
scavenging system in TBS2Xtw supplemented with 0.1 v/v
murine RNAase inhibitor) before imaging on a custom configured
Zeiss Axio Observer Z1 with 63× planapo objective, Zyla 4.2
sCMOS, and custom LED light engine built for MERFISH (Fore-
man & Wollman, 2020).
Images were background subtracted by difference of Gaussian fil-
tering with a high pass filter of 2.5 pixel sigma and 0.8 pixel low
pass blurring filter. Local maxima were detected, and a 3 × 3 pixel
region around local maxima intensity averaged. Number of spots
found as a function of spot intensity was used to hysteresis thresh-
old background spots from mRNA spots (Tsanov et al, 2016). Nuclei
were segmented using watershed seed with smoothed local maxima
in valleys of the negative smoothed intensity of the DAPI channel.
Cells were imaged in a Green channel that produces smooth autoflu-
orescence around the cell cytoplasm, and cytoplasm was segmented
using the nuclei segmentation as seeds in a valley of negative
autofluorescence intensity. RNA spots were assigned to cells if the
cellular segmentation mask contained a particular spot. Cellular
areas were calculated for each cell and used in volume normaliza-
tion of RNA counts. Raw counts were normalized by dividing the
count by the area of each cell and multiplying by the average area
of all cells to rescale counts back to the same means as before
normalization. These volume normalized counts were log2 trans-
formed with a pseudo-count of 1. Fraction of responders was calcu-
lated by finding the fraction of cells with an A20 count > 1
transcript per cell at each timepoint.
CRISPR/Cas9-gene editing
Guide RNAs (gRNAs, Table EV3) were cloned into lentiCRISPR v2
(52961, Addgene) (Sanjana et al, 2014) and used for lentivirus
production in HEK293T cells. Infected L929 cells were selected with
Puromycin (8 µg/ml) until cell death subsided, used for experiments
or subjected to single-cell sorting and clonal expansion as indicated.
Knockout was confirmed by Western blot or—in the case of cIAP2
—by HRM analysis. To this end, genomic DNA was isolated using
Quick-DNA Miniprep Plus (Zymogen) and subjected to PCR amplifi-
cation (50 – ACAGTCCCATGGAGAAGCAC – 30, and 50 –
CTTGTGCTCAAAGCAGGACA – 30), and subsequent melt curve
analysis using SYBR Green (Bio-Rad) and temperature increments
(0.2°C steps).
Transfection of short interference (si) RNA
Reverse transfection of L929 cells (Metzig et al, 2011a; Metzig et al,
2011b) was performed using transfection reagent (DharmaFECT1)
and siRNAs (Dharmacon) at a final concentration of 50 nM. After
24 h, knockdown efficiencies were tested prior to and in response to
TNF treatment on mRNA and protein level as indicated.
Expression of A20 transgenes
pBabe-A20 containing a human A20 ORF was used for retroviral
production (Werner et al, 2008) and infection of L929 RelA-knock-
out cells. In L929 A20-knockout cells, inducible A20 was reconsti-
tuted from transgene fIL8-A20 containing A20 ORF under the
control of the IL8-promoter (Lois et al, 2002; Werner et al, 2008).
Data reproducibility and statistical analysis
Each experiment was repeated at least three independent times and
performed in different weeks. All measurements were taken from
distinct cellular samples, rather than measuring the same sample
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repeatedly. Microscopy analysis and all other data or images
presented in the same figure panel were taken from measuring the
respective conditions side-by-side in the same independent experi-
ment. Statistical analysis was performed on means of these three
individual experiments using two-tailed Student’s t-test with P
values noted in respective figure legends.
Data availability
The datasets and computer code produced in this study are available
in the following databases:
• NFκB-necroptosis modeling code: Dryad (https://doi.org/10.
5068/D1W09)
• Live-cell imaging: Dryad (https://doi.org/10.5068/D1C38J)
• NECtrack package: Dryad (https://doi.org/10.5068/D1W09J)
• smFISH code and source images: Figshare (accessory files:
https://doi.org/10.6084/m9.figshare.12769667; Dataset 1: https:
//doi.org/10.6084/m9.figshare.12769658; Dataset 2: https://doi.
org/10.6084/m9.figshare.12769655; Dataset 3: https://doi.org/10.
6084/m9.figshare.12769661
Expanded View for this article is available online.
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